Close

Virginia adopts national precursor log exchange system

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

McKesson Acquires Controlling Stake in PRISM Vision

McKesson Corporation has announced its agreement to acquire a...

CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review

CluePoints continues to transform clinical trial review and leverage its...

ML And AI Transforming Pharmaceutical R&D And Drug Discovery

Richard Lee, Director, Core Technology and Capabilities, ACD/Labs, says...

TraceLink’s Magnum Release of Platform for Supply Chain Management

TraceLink, the largest end-to-end digital network platform for intelligent...

The commonwealth of Virginia has adopted a real-time, stop-sale technology known as national precursor log exchange system.

NPLEx targets methamphetamine criminals, while protects law-abiding consumers’ access to safe and effective medicines containing pseudoephedrine (PSE) including Advil Cold & Sinus, Allegra-D, Claritin-D, Mucinex D, and Sudafed. NPLEx provides a secure, interconnected electronic logbook that tracks and logs every PSE sale in every store at the moment it is happening.

The system also provides law enforcement officials with a new and effective tool in the fight against meth and can block the illegal sale in real-time and across state lines. Consumer Healthcare Products Association president and chief executive officer Scott Melville said the company applaud Gov. McDonnell, Senators Lucas and Stuart, the Virginia legislature, and Virginia law enforcement for implementing a proven solution that will fight domestic meth production while maintaining consumer access to widely used cold and allergy medicines.

Latest stories